AI Article Synopsis

  • The study evaluates a hospital-based lifestyle program on women with metabolic syndrome (MetS) through diet and exercise over an 8-week period.
  • Forty-four participants showed significant improvements in all MetS components, with 25% no longer classified with MetS after the program.
  • The program highlights the potential of lifestyle changes to lower cardiovascular disease risk in women with MetS, although it did not significantly impact high-density lipoprotein cholesterol levels.

Article Abstract

Objective: The aim of the present study is to evaluate the effect of a hospital-based therapeutic lifestyle program on women with metabolic syndrome (MetS).

Materials And Methods: We conducted a therapeutic lifestyle program for women with MetS. They all received a low calorie, balanced diet and participated in a regular aerobic exercise program for 8 weeks. Anthropometric indices, blood pressure, and biochemical data were collected. A paired t test was used for statistical analysis. A p value of less than 0.05 was considered statistically significant.

Results: Forty-four women took part in the program. All the components of MetS had decreased significantly by the end of the program and 25% of women no longer had MetS at the end of the program.

Conclusion: The therapeutic lifestyle program with diet control and regular exercise improves most markers of MetS except for levels of high density lipoprotein cholesterol. Therapeutic lifestyle intervention may be the best way of reducing the risk of cardiovascular disease in women with MetS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1028-4559(10)60094-0DOI Listing

Publication Analysis

Top Keywords

therapeutic lifestyle
20
lifestyle program
16
program women
12
hospital-based therapeutic
8
women metabolic
8
metabolic syndrome
8
women mets
8
program
7
women
6
lifestyle
5

Similar Publications

Background: Digital health technology (DHT) has the potential to revolutionize the health care industry by reducing costs and improving the quality of care in a sector that faces significant challenges. However, the health care industry is complex, involving numerous stakeholders, and subject to extensive regulation. Within the European Union, medical device regulations impose stringent requirements on various ventures.

View Article and Find Full Text PDF

Previous cross-sectional studies have utilized scales to explore potential indications of the moderating effect of resilience on the relationship between stressful life events (SLEs) and mental health. However, there remains a notable dearth of psychometrically driven models in longitudinal resilience research, especially concerning the prognosis of individuals with affective disorders and/or anxiety. This study aimed to investigate whether baseline resilience capacity, measured by the Connor-Davidson Resilience Scale, could mitigate the impact of SLEs on depressive symptoms assessed using the Beck Depression Inventory-II among 66 outpatients with depression and/or anxiety disorders during a follow-up period ranging from 4-8 years.

View Article and Find Full Text PDF

Gastric cancer, a prevalent malignant tumor worldwide, poses a significant challenge to global health. Despite ongoing advancements in treatment methods, its high incidence and mortality rates remain concerning. Although progress in treating gastric cancer is encouraging, a more critical focus is on enhancing prevention efforts.

View Article and Find Full Text PDF

Background: By 2060, an estimated 3.5 million Latinos may develop Alzheimer's disease (AD). Lifestyle factors, such as adhering to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, may improve cognition and reduce AD risk.

View Article and Find Full Text PDF

Background: Non-steroidal anti-inflammatory (NSAID) medication are suggested to have beneficial effects in the prevention of Alzheimer's disease, due to anti-inflammatory and possibly amyloid-lowering properties. However, the results of observational studies and randomized-controlled trials have been inconsistent, and duration and dose-response relationships are still unclear.

Method: We included 11,745 dementia-free participants from the prospective population-based Rotterdam Study (59.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!